ArticleJournal of global health2026
Influenza vaccine protection and contact patterns among outpatients with influenza-like illness during the 2024-2025 season in China: a test-negative case-control study.
Article in Journal of global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Continuous monitoring of both influenza vaccine protection and behavioural determinants of infection is important for understanding related risks. Evidence on influenza vaccine effectiveness (VE) in China during the 2024-2025 season, however, remains limited. We aimed to assess influenza VE among healthcare-seeking outpatients with influenza-like illness (ILI) and to examine the contact patterns associated with infection risk. Methods: We enrolled 928 outpatients with ILI from three sentinel hospitals in Ili Kazakh Autonomous Prefecture, China, between December 2024 and March 2025 in a test-negative case-control study. We confirmed influenza infection using reverse transcription-polymerase chain reaction and collected vaccination history and social contact frequency and duration through questionnaires. We estimated VE using logistic regression with covariate adjustment, and otherwise analysed social contact patterns and performed exploratory sequencing of six randomly selected influenza-positive samples. Results: Our full sample comprised 928 participants. We excluded 21 infants younger than 6 months from the VE analysis and included 907 participants, of whom 121 tested positive and 786 tested negative. The overall adjusted VE against medically attended influenza was 42.3% (95% credible interval = 11.1-62.5). In the analysis of social contacts for all 928 participants, test-positive children aged 0-10 years and adults aged 65 years or older reported more frequent and longer social contact than their test-negative counterparts. Exploratory sequencing of six samples suggested no major antigenic mismatch with the vaccine strains, but the very small number of sequenced samples limits the generalisability of this finding. Conclusions: Influenza vaccination provided moderate protection against medically attended influenza, while contact patterns were associated with infection risk among children and older adults. Combined vaccination and behavioural interventions warrant further evaluation, as the observational design of this study and its use of self-reporting data limit causal inference.
Indexed as
Identifiers
42852605What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.